These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30413641)

  • 21. Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Low CL; Gopalakrishna K; Lye WC
    J Am Soc Nephrol; 2000 Jun; 11(6):1117-1121. PubMed ID: 10820176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
    Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of culture-directed antibiotics for the treatment of peritonitis in automated peritoneal dialysis: A systematic narrative review.
    Ling CW; Sud K; Van C; Zaidi STR; Patel RP; Peterson GM; Castelino RL
    Perit Dial Int; 2021 May; 41(3):261-272. PubMed ID: 33559525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
    Fuiano G; Sepe V; Viscione M; Nani E; Conte G
    Perit Dial Int; 1989; 9(4):273-5. PubMed ID: 2488380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.
    Huen SC; Hall I; Topal J; Mahnensmith RL; Brewster UC; Abu-Alfa AK
    Am J Kidney Dis; 2009 Sep; 54(3):538-41. PubMed ID: 19237231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C
    Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
    Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Intraperitoneal Interleukin-6 Levels Predict Peritonitis in Peritoneal Dialysis Patients: A Prospective Cohort Study.
    Yang X; Tong Y; Yan H; Ni Z; Qian J; Fang W
    Am J Nephrol; 2018; 47(5):317-324. PubMed ID: 29779030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients.
    Goedde M; Sitter T; Schiffl H; Bechtel U; Schramm W; Spannagl M
    Perit Dial Int; 1997; 17(2):162-6. PubMed ID: 9159837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.
    Bargman JM; Jones JE; Petro JM
    Perit Dial Int; 1992; 12(4):369-72. PubMed ID: 1420495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics of ceftazidime injected peritoneally in continuous ambulatory peritoneal dialysis].
    Ryckelynck JP; Vergnaud M; Hurault de Ligny B; Allouche G; Malbruny B; Morel C
    Pathol Biol (Paris); 1986 May; 34(5):328-31. PubMed ID: 3534700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis.
    Stea S; Bachelor T; Cooper M; de Souza P; Koenig K; Bolton WK
    J Am Soc Nephrol; 1996 Nov; 7(11):2399-402. PubMed ID: 8959631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of exchange-free periods alternating with daily exchanges of icodextrin in the initial treatment of peritoneal dialysis-associated peritonitis: a safety study.
    Yehia M; Muyoma G; Topley N; Collins JF
    Perit Dial Int; 2014; 34(7):810-3. PubMed ID: 25520490
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?
    Bailie GR; Morton R; Ganguli L; Keaney M; Waldek S
    Nephron; 1987; 46(3):316-8. PubMed ID: 3627326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis.
    Blowey DL; Warady BA; Abdel-Rahman S; Frye RF; Manley HJ
    Perit Dial Int; 2007; 27(1):79-85. PubMed ID: 17179516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient.
    Goedecke VA; Clajus C; Burkhardt O; Martens-Lobenhoffer J; Bode-Boger SM; Kielstein JT; Hiss M
    Scand J Infect Dis; 2009; 41(2):155-7. PubMed ID: 19085620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Ateshkadi A; Johnson CA; Oxton LL; Hammond TG; Bohenek WS; Zimmerman SW
    Am J Kidney Dis; 1993 Jun; 21(6):635-42. PubMed ID: 8503418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovations in Treatment Delivery, Risk of Peritonitis, and Patient Retention on Peritoneal Dialysis.
    Piraino B
    Semin Dial; 2017 Mar; 30(2):158-163. PubMed ID: 28066919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival.
    Srivastava S; Hildebrand S; Fan SL
    Kidney Int; 2011 Nov; 80(9):986-991. PubMed ID: 21814174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of once-daily IP gentamicin in CAPD patients.
    Low CL; Bailie GR; Evans A; Eisele G; Venezia RA
    Perit Dial Int; 1996; 16(4):379-84. PubMed ID: 8863331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.